By Sheeba M. | Weedstock Market Intelligence
Monday, September 28, 2026
Green Thumb Industries (GTBIF) is trading as a focal point for institutional cannabis positioning Monday afternoon, with the DEA rescheduling final-4 countdown providing the most consequential near-term catalyst backdrop the sector has faced since SAFE Banking failed in 2022. Midday price action suggests accumulation behavior from multi-week holders building ahead of an expected October ruling window.
Q3 2026 Earnings Preview: What the Numbers Should Show
Green Thumb is expected to report Q3 2026 results in early November. The company has been executing a disciplined retail and wholesale expansion across its RISE dispensary network, now operating 100+ doors across 15 states, while maintaining one of the strongest adjusted EBITDA margins in the multi-state operator (MSO) universe.
- Revenue trajectory: GTI running at approximately $280-310M quarterly, with Illinois and New Jersey contributing the heaviest volume. A Q3 print above $300M signals continued organic growth independent of the regulatory catalyst.
- Adjusted EBITDA margin: The company has maintained 25-28% adjusted EBITDA margins through the 280E drag cycle. Schedule III reclassification would unlock an estimated $40-60M in annualized tax savings based on current operating income.
- Cash position: GTI balance sheet discipline has been a differentiator. Any signal of refinancing activity or capital returns in Q3 results would be materially positive for valuation multiples.
Illinois: The Foundation That Doesn’t Get Enough Credit
Green Thumb’s Illinois footprint remains the crown jewel of its multi-state portfolio. The state’s limited-license adult-use market has created structural competitive advantages for operators with legacy positioning, and GTI has leveraged its early-mover status into consistent market share defense. Illinois adult-use sales have stabilized at $150M+ monthly statewide. The company’s RHYTHM brand continues to perform as one of the top-selling cannabis brands in Illinois.
Florida: Medical Market Positioning
Green Thumb’s Florida operation is a strategic asset being re-priced by market participants. With Florida’s medical cannabis market generating consistent volume and adult-use ballot initiatives continuing to circulate, GTI’s 12+ dispensary Florida presence provides optionality not fully priced into OTC multiples. Competitors like Curaleaf (CURLF) dominate Florida market share by dispensary count, but GTI’s operational efficiency ratios in Florida have historically outperformed its footprint size.
280E / Schedule III: The Thesis That Drives the Trade
The core bull case for GTBIF remains the 280E elimination thesis tied to DEA Schedule III reclassification:
- Current effective tax rates under 280E are running 60-80% for profitable MSOs, versus 21% federal statutory rate for normal corporations
- GTI 2025 annual operating income approximately $130-150M; normalized tax rate generates $40-60M incremental annual free cash flow
- At current EV/EBITDA multiples (approximately 8-12x for GTBIF), the FCF improvement alone represents 20-35% upside in enterprise value before growth assumptions
MSO Peer Comparison
Within the MSO universe, GTBIF competes for institutional allocation against Curaleaf (CURLF), Verano Holdings (VRNOF), and Trulieve (TCNNF). On a risk-adjusted basis heading into the DEA catalyst, GTI’s balance sheet is cleaner than most peers, Illinois concentration is a proven market with pricing stability, and management execution scores have been consistently above MSO peer average.
Forward-Looking Catalysts
- DEA ruling (October window): Schedule III finalization removes 280E drag and re-rates the sector
- Q3 earnings (early November): Revenue and margin beats validate organic growth thesis
- Illinois adult-use data: Monthly state-level sales data informs market share tracking
- Capital allocation signals: Buybacks or debt reduction signal management FCF confidence
This article is for informational purposes only and does not constitute investment advice. Cannabis equities involve significant risk including regulatory uncertainty, liquidity constraints, and sector-specific volatility.